Form 4: Guardant Health Executive Reports Stock Transaction
Insider Transaction (Form 4)
Kumud Kalia, Chief Information Officer of Guardant Health, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 1,607 Common Stock on October 1, 2026; holds 41,401 after (Direct).
- Option exercise/conversion: acquired 1,084 Common Stock on October 1, 2026; holds 42,485 after (Direct).
- Option exercise/conversion: acquired 1,995 Common Stock on October 1, 2026; holds 44,480 after (Direct).
- Option exercise/conversion: acquired 1,360 Common Stock on October 1, 2026; holds 45,840 after (Direct).
- Tax/exercise-price withholding: disposed of 3,067 Common Stock at $174.75 ($535,958) on October 1, 2026; holds 42,773 after (Direct).
- Option exercise/conversion: disposed of 1,607 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 1,084 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 1,995 Restricted Stock Units on October 1, 2026; holds 7,978 after (Direct).
- Option exercise/conversion: disposed of 1,360 Restricted Stock Units on October 1, 2026; holds 8,162 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kumud Kalia — Officer (Chief Information Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,607 | — | — | 41,401 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,084 | — | — | 42,485 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,995 | — | — | 44,480 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,360 | — | — | 45,840 |
| 2026-10-01 | Tax/exercise-price withholding | Common Stock | 3,067 | $175 | $536.0K | 42,773 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,607 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,084 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,995 | — | — | 7,978 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,360 | — | — | 8,162 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (1,607 shares) |
| 2026-10-01 | Option exercise/conversion (1,084 shares) |
| 2026-10-01 | Option exercise/conversion (1,995 shares) |
| 2026-10-01 | Option exercise/conversion (1,360 shares) |
| 2026-10-01 | Tax/exercise-price withholding (3,067 shares) |
| 2026-10-01 | Option exercise/conversion (1,607 shares) |
| 2026-10-01 | Option exercise/conversion (1,084 shares) |
| 2026-10-01 | Option exercise/conversion (1,995 shares) |
| 2026-10-01 | Option exercise/conversion (1,360 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, Kumud Kalia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.